v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Jan. 31, 2026
Cash flows from operating activities:      
Net loss $ (20,506) $ (61,257)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Stock-based compensation, net of amounts capitalized 37,312 17,260  
Non-cash interest expense 447 9,941  
Deferred income taxes (886) 0  
Depreciation and amortization 5,721 5,931  
Amortization of contract acquisition costs 2,367 1,231  
Provision for doubtful accounts 1,871 2,274  
Loss on fair value adjustments 0 10,136  
Debt issuance costs expensed related to SAFEs 0 2,913  
Loss on extinguishment of debt 0 20,528  
Other 460 (375)  
Changes in operating assets and liabilities:      
Accounts receivable (13,730) 5,573  
Prepaid expenses and other current assets 2,520 (9,963)  
Contract acquisition costs (6,428) (2,503)  
Other non-current assets 381 738  
Accounts payable (774) (720)  
Accrued expenses and other current liabilities (9,397) (1,359)  
Deferred revenue (1,912) 3,363  
Operating lease right-of-use asset and operating lease liabilities, net (146) (181)  
Other non-current liabilities (4,098) 1,021  
Net cash provided by (used in) operating activities (6,798) 4,551  
Cash flows from investing activities:      
Capitalized software development costs (4,647) (3,927)  
Purchases of property and equipment (105) (90)  
Purchases of investments (59,101) 0  
Maturities of investments 53,460 0  
Change in corporate card receivables (18,336) 1,589  
Other 0 (418)  
Net cash (used in) investing activities (28,729) (2,846)  
Cash flows from financing activities:      
Proceeds from stock option exercises 14,731 1,583  
Proceeds from borrowings of debt 0 174,945  
Proceeds from issuance of SAFEs 0 155,000  
Payments of borrowings of debt (293) (258,534)  
Payments for debt issuance costs 0 (10,985)  
Payments of deferred offering costs (407) 0  
Net cash provided by financing activities 14,031 62,009  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,566) 4,783  
Net increase (decrease) in cash, cash equivalents and restricted cash (23,062) 68,497  
Cash, cash equivalents and restricted cash, beginning of period 668,074 310,595 $ 310,595
Cash, cash equivalents and restricted cash, end of period 645,012 379,092 $ 668,074
Supplemental disclosure of cash flow information:      
Cash paid for interest 2,375 6,395  
Cash paid for income taxes 3,083 5,647  
Noncash investing and financing activities:      
Vesting of early exercised stock options 38 287  
Capitalized stock-based compensation for internal-use software development costs $ 1,074 $ 570